Chronic Lymphocytic Leukemia (CLL)

1
Chronic Lymphocytic Leukemia (CLL)
2
Faculty
3
Chronic Lymphocytic Leukemia
4
(No Transcript)
5
(No Transcript)
6
CLL Pathogenesis
7
Model of Microenvironment Interactions
8
Role of Cytokines in CLL Biology
9
Role of Immune Stimulation in CLL
10
Risk Factors
11
Familial Incidence
12
Clinical Course
13
Clinical Course
14
(No Transcript)
15
Diagnosis NCI-WG
16
B-CLL vs Other Chronic Lymphoproliferative
Disorders Differential Diagnosis
17
Staging Systems
18
Traditional Prognostic Factors
19
Survival By Rai StageUntreated CLL
20
(No Transcript)
21
Prognostic Nomogram Using ?2-Microglobulin
Clinical Parameters
22
(No Transcript)
23
Genomic Aberrations in CLLInterphase FISH
Results82 Abnormal
24
CLL Disease ProgressionFISH Stratification
25
(No Transcript)
26
(No Transcript)
27
CD38 as a Prognostic Factor
28
(No Transcript)
29
Survival Based on IgVH Gene Mutation Status and
CD38 Expression
30
ZAP-70 as a Prognostic Factor
31
Gene Expression Profiling in CLL and ZAP-70
32
Prognostic Value of ZAP-70 in Patients With Stage
A Binet CLL Survival
33
(No Transcript)
34
Time From Diagnosis to Initial Therapy by
ZAP-70 and IgVH
35
Prognostic FactorsSummary
36
NCI-WG Indications to Treat1996-2007
37
International Workshop on Chronic Lymphocytic
Leukemia (IWCLL) 2008 Revised Indications for
Treatment
38
Defining CR in CLLNCI-WG Criteria1996-2007
39
International Workshop on Chronic Lymphocytic
Leukemia (IWCLL) Revised CR Criteria for General
Practice
40
International Workshop on Chronic Lymphocytic
Leukemia (IWCLL)Other Response Definition
Revisions
41
Minimal Residual Disease (MRD)as Potential
Therapy Endpoint
42
Long-Term ComplicationsIncidence
43
Richters Transformation